Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,110 | -8,600 | -6,330 | -6,220 | -3,640 |
| Depreciation Amortization | 1,650 | 1,500 | 1,130 | 1,120 | 1,160 |
| Other Working Capital | 1,810 | -590 | 2,750 | 1,090 | -910 |
| Other Operating Activity | 1,500 | 130 | -260 | 930 | 120 |
| Operating Cash Flow | $-6,150 | $-7,560 | $-2,710 | $-3,080 | $-3,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,160 | -3,310 | -4,140 | -400 | -510 |
| Net Acquisitions | 0 | 0 | 0 | 1,660 | 0 |
| Other Investing Activity | -200 | 3,750 | -2,070 | 2,190 | -3,740 |
| Investing Cash Flow | $-1,360 | $440 | $-6,210 | $3,450 | $-4,250 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,780 | 16,660 | 10,610 | -700 | 5,640 |
| Financing Cash Flow | $1,780 | $16,660 | $10,610 | $-700 | $5,640 |
| Beginning Cash Position | 14,880 | 5,340 | 3,660 | 3,990 | 5,880 |
| End Cash Position | 9,140 | 14,880 | 5,340 | 3,660 | 3,990 |
| Net Cash Flow | $-5,730 | $9,530 | $1,680 | $-330 | $-1,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,150 | -7,560 | -2,710 | -3,080 | -3,270 |
| Free Cash Flow | -6,150 | -7,560 | -2,710 | -3,080 | -3,270 |